Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute. Learn more about Cancer Currents.
-
Overdiagnosis of Cancer: Bringing an Important Problem into FocusExperts are convening for a conference on the dilemmas posed by overdiagnosis in many types of diseases. Overdiagnosis is generally defined as the diagnosis of a disease or condition that is unlikely to ever cause harm.
-
Risk of Breast Cancer Death is Low After a Diagnosis of Ductal Carcinoma in SituWomen who are diagnosed with a condition called ductal carcinoma in situ generally have a low risk of dying from breast cancer, a new study has found.
-
FDA Approves Expanded Indication for Carfilzomib in Patients with Multiple MyelomaThe FDA has approved carfilzomib in combination with other anticancer drugs to treat patients with relapsed multiple myeloma.
-
With FDA Approval, Gefitinib Returns to U.S. Market for Some Patients with Lung CancerThe FDA last month approved gefitinib (Iressa) for the treatment of some patients with lung cancer, marking the drug’s return to the U.S. market after an earlier withdrawal.
-
Gene Therapy Approach for Ovarian Cancer Shows Encouraging Signs in Animal ModelA single injection of a gene therapy viral vector inhibited tumor growth of some mouse tumors derived from patients with recurrent ovarian cancer.
-
Too Few Patients with Cancer Communicate Preferences for End-of-Life CareMany patients with cancer and their physicians are not communicating about the patients’ preferences for end-of-life medical care, a new study suggests.
-
NCI-Designated Cancer Centers Expand, Four Awarded Comprehensive DesignationIn July 2015, the NCI’s cancer centers program expanded by adding a new institution and awarding the comprehensive designation to four existing NCI-designated cancer centers.
-
What’s New Online from NCI?NCI periodically provides updates on new websites and other online content of interest to the cancer community.
-
New Research: Using Lung Cancer Screening As An Opportunity to Help Smokers QuitNCI has released a new funding announcement to stimulate research on optimal smoking cessation approaches delivered in conjunction with lung cancer screening.
-
U.S. Indoor Tanning Rates Are Dropping, But Still HighStudy estimates about 1.6 million fewer women and 400,000 fewer men tan indoors, but it’s still a common practice.
-
Oncolytic Virus Therapy Shows Benefit in Patients with MelanomaIn a large clinical trial, the oncolytic virus therapy T-VEC improved the durable response rate and median survival in patients with advanced melanoma.
-
Setting the Course: Genomics Workshop on Childhood Cancers Identifies Research OpportunitiesNCI recently convened a workshop to discuss the status of genomic characterization for childhood cancers and to identify opportunities for future research.
-
Pancreatic Cancer Study Finds Possible Diagnostic Marker in BloodA protein attached to vesicles circulating in the blood could be a biological marker for detecting early signs of pancreatic cancer.
-
Test May Identify Poor Prognosis for Some Patients with Lung CancerA panel of three genetic markers may help to identify patients with early-stage lung cancer who have a very strong likelihood of their disease returning after surgery.
-
Next Round of Grant Solicitations for Provocative Questions AnnouncedThe next round of grant solicitations for Provocative Questions has been announced.
-
Cancer Currents Now Available in SpanishAs part of our effort to more effectively reach patients, health care providers, and researchers with timely, authoritative, and scientifically accurate cancer information, we are now offering selected Cancer Currents blog posts in Spanish.
-
NCI Launches Competition to Spur Research on Breast Cancer Genomics, Disease RiskLast month, NCI launched a competition to spur research in an area of great public health interest: the genomic basis of breast cancer and breast cancer risk.
-
In Mice, New Drug Conjugate Suggests Promise for Hard-to-Treat Pediatric CancersFindings from a study in mice suggests that a new type of drug conjugate may have potential as a treatment for two cancers that are often diagnosed in children.
-
Many Women with Dense Breasts May Not Need Additional ScreeningBreast density is just one of several factors that should be taken into account in determining the need for additional cancer screening, study suggests.
-
Using Gene Expression to Diagnose Lung Cancer More AccuratelyA pattern of gene expression in the cells of the upper airways of patients with suspected lung cancer can help to diagnose lung cancer more accurately than bronchoscopy alone.